CRP/Albumin Ratio: An Early Predictor of Steroid Responsiveness in Acute Severe Ulcerative Colitis

被引:79
作者
Gibson, David J. [1 ,2 ]
Hartery, Karen [1 ,2 ]
Doherty, Jayne [1 ,2 ]
Nolan, Jack [1 ,2 ]
Keegan, Denise [1 ,2 ]
Byrne, Kathryn [1 ,2 ]
Martin, Sean T. [1 ,2 ]
Buckley, Maire [1 ,2 ]
Sheridan, Juliette [1 ,2 ]
Horgan, Gareth [1 ,2 ]
Mulcahy, Hugh E. [1 ,2 ]
Cullen, Garret [1 ,2 ]
Doherty, Glen A. [1 ,2 ]
机构
[1] St Vincents Univ Hosp, Ctr Colorectal Dis, Elm Pk, Dublin 4, Ireland
[2] Univ Coll Dublin, Sch Med, Dublin, Ireland
关键词
acute severe colitis; steroid response; CRP; albumin ratio; RESCUE THERAPY; INFLIXIMAB THERAPY; COLECTOMY; CYCLOSPORINE; MANAGEMENT; EFFICACY; SAFETY; TRIAL; RISK; NEED;
D O I
10.1097/MCG.0000000000000884
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Introduction:Identifying hospitalized patients with acute severe ulcerative colitis (ASUC) who will be refractory to corticosteroid therapy and require rescue therapy remains difficult. Hypoalbuminemia worsens with time during hospitalization and is associated with rapid clearance of and reduced response to infliximab (IFX) rescue. Early use of rescue therapy may therefore be more effective. Simple clinical and laboratory predictors of corticosteroid responsiveness would facilitate earlier use of rescue therapy.Materials and Methods:Retrospective study of a prospectively maintained database of 3600 patients attending a single center was conducted. Patients with histologically confirmed ulcerative colitis admitted with ASUC over a 5-year period from January 2010 to December 2014 were identified. All patients initially received intravenous corticosteroids. Patient demographics were collected; C-reactive protein (CRP) and albumin levels were recorded at baseline and during admission. Receiver operating characteristic statistics were used to determine the optimal stool frequency, CRP, albumin, and CRP/albumin ratio (CAR) to predict steroid response.Results:A total of 124 ASUC patients were admitted during a 5-year period. Median follow-up was 2.3 years. A total of 62 patients (50%) were steroid responsive, 55 patients (44%) received rescue IFX, 22 patients (18%) required colectomy within 30 days of admission, whereas a further 14 (11%) required colectomy during follow-up. By receiver operating characteristic statistics, day 3 CAR was a more accurate marker of steroid responsiveness than day 3 CRP or day 3 albumin alone [area under curve=0.75 (P<0.001)]. The optimal CAR to predict response to steroids on day 3 was 0.85 (sensitivity 70%, specificity 76%). When combined with D3 stool frequency, specificity improved to 83%. If at day 3, CAR was >0.85 and stool frequency was >3, the relative risk of steroid nonresponse was significantly raised at 3.9 (95% confidence interval, 2.1-7.2).Conclusions:Raised D3 CAR is an early predictor of steroid-refractory ASUC. When combined with D3 stool frequency, its predictive ability improves. In patients with predicted steroid nonresponse, early introduction of rescue IFX at this stage may be more effective, before serum albumin falls profoundly.
引用
收藏
页码:E48 / E52
页数:5
相关论文
共 21 条
[1]   A Panel to Predict Long-term Outcome of Infliximab Therapy for Patients With Ulcerative Colitis [J].
Arias, Maria Theresa ;
Casteele, Niels Vande ;
Vermeire, Severine ;
van Overstraeten, Anthony de Buck ;
Billiet, Thomas ;
Baert, Filip ;
Wolthuis, Albert ;
Van Assche, Gert ;
Noman, Maja ;
Hoffman, Ilse ;
D'Hoore, Andre ;
Gils, Ann ;
Rutgeerts, Paul ;
Ferrante, Marc .
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2015, 13 (03) :531-538
[2]   Pharmacokinetic Features and Presence of Antidrug Antibodies Associate With Response to Infliximab Induction Therapy in Patients With Moderate to Severe Ulcerative Colitis [J].
Brandse, Johannan F. ;
Mathot, Ron A. ;
van der Kleij, Desiree ;
Rispens, Theo ;
Ashruf, Yael ;
Jansen, Jeroen M. ;
Rietdijk, Svend ;
Lowenberg, Mark ;
Ponsioen, Cyriel Y. ;
Singh, Sharat ;
van den Brink, Gijs R. ;
D'Haens, Geert R. .
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2016, 14 (02) :251-+
[3]   Second European evidence-based consensus on the diagnosis and management of ulcerative colitis Part 1: Definitions and diagnosis [J].
Dignass, Axel ;
Eliakim, Rami ;
Magro, Fernando ;
Maaser, Christian ;
Chowers, Yehuda ;
Geboes, Karel ;
Mantzaris, Gerassimos ;
Reinisch, Walter ;
Colombel, Jean-Frederic ;
Vermeire, Severine ;
Travis, Simon ;
Lindsay, James O. ;
Van Assche, Gert .
JOURNAL OF CROHNS & COLITIS, 2012, 6 (10) :965-990
[4]   An Accelerated Infliximab Induction Regimen Reduces the Need for Early Colectomy in Patients With Acute Severe Ulcerative Colitis [J].
Gibson, David J. ;
Heetun, Zaid S. ;
Redmond, Ciaran E. ;
Nanda, Kavin S. ;
Keegan, Denise ;
Byrne, Kathryn ;
Mulcahy, Hugh E. ;
Cullen, Garret ;
Doherty, Glen A. .
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2015, 13 (02) :330-U170
[5]   The C-reactive Protein to Albumin Ratio Predicts Long-Term Outcomes in Patients with Pancreatic Cancer After Pancreatic Resection [J].
Haruki, Koichiro ;
Shiba, Hiroaki ;
Shirai, Yoshihiro ;
Horiuchi, Takashi ;
Iwase, Ryota ;
Fujiwara, Yuki ;
Furukawa, Kenei ;
Misawa, Takeyuki ;
Yanaga, Katsuhiko .
WORLD JOURNAL OF SURGERY, 2016, 40 (09) :2254-2260
[6]   Management of acute severe colitis [J].
Jakobovits, Simon L. ;
Travis, S. P. L. .
BRITISH MEDICAL BULLETIN, 2005, 75-76 :131-144
[7]   The C-Reactive Protein/Albumin Ratio as an Independent Predictor of Mortality in Patients with Severe Sepsis or Septic Shock Treated with Early Goal-Directed Therapy [J].
Kim, Min Hyung ;
Ahn, Jin Young ;
Song, Je Eun ;
Choi, Heun ;
Ann, Hea Won ;
Kim, Jae Kyoung ;
Kim, Jung Ho ;
Jeon, Yong Duk ;
Kim, Sun Bean ;
Jeong, Su Jin ;
Ku, Nam Su ;
Han, Sang Hoon ;
Song, Young Goo ;
Choi, Jun Young ;
Kim, Young Sam ;
Kim, June Myung .
PLOS ONE, 2015, 10 (07)
[8]   Ciclosporin versus infliximab in patients with severe ulcerative colitis refractory to intravenous steroids: a parallel, open-label randomised controlled trial [J].
Laharie, David ;
Bourreille, Arnaud ;
Branche, Julien ;
Allez, Matthieu ;
Bouhnik, Yoram ;
Filippi, Jerome ;
Zerbib, Frank ;
Savoye, Guillaume ;
Nachury, Maria ;
Moreau, Jacques ;
Delchier, Jean-Charles ;
Cosnes, Jacques ;
Ricart, Elena ;
Dewit, Olivier ;
Lopez-Sanroman, Antonio ;
Dupas, Jean-Louis ;
Carbonnel, Franck ;
Bommelaer, Gilles ;
Coffin, Benoit ;
Roblin, Xavier ;
Van Assche, Gert ;
Esteve, Maria ;
Farkkila, Martti ;
Gisbert, Javier P. ;
Marteau, Philippe ;
Nahon, Stephane ;
de Vos, Martine ;
Franchimont, Denis ;
Mary, Jean-Yves ;
Colombel, Jean-Frederic ;
Lemann, Marc .
LANCET, 2012, 380 (9857) :1909-1915
[9]   Efficacy, safety, and predictors of response to infliximab therapy for ulcerative colitis: A Korean multicenter retrospective study [J].
Lee, Kang-Moon ;
Jeen, Yoon Tae ;
Cho, Ju Yeon ;
Lee, Chang Kyun ;
Koo, Ja-Seol ;
Park, Dong Il ;
Im, Jong Pil ;
Park, Soo Jung ;
Kim, You Sun ;
Kim, Tae Oh ;
Lee, Suck-Ho ;
Jang, Byung Ik ;
Kim, Ji Won ;
Park, Young Sook ;
Kim, Eun-Soo ;
Choi, Chang Hwan ;
Kim, Hyo Jong .
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2013, 28 (12) :1829-1833
[10]   A retrospective analysis of the efficacy and safety of infliximab as rescue therapy in acute severe ulcerative colitis [J].
Lees, C. W. ;
Heys, D. ;
Ho, G. T. ;
Noble, C. L. ;
Shand, A. G. ;
Mowat, C. ;
Boulton-Jones, R. ;
Williams, A. ;
Church, N. ;
Satsangi, J. ;
Arnott, I. D. R. .
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2007, 26 (03) :411-419